Development of Choroid Plexus and the Blood-CSF Barrier

脉络丛和血脑脊液屏障的发育

基本信息

  • 批准号:
    7140269
  • 负责人:
  • 金额:
    $ 18.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-15 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Blood-tissue barriers protect the central nervous system and represent the major interfaces between the central nervous system and peripheral circulation. Damage to the barriers leads to long-term neurological toxicity in the development of many neurological diseases. Barriers are found in the brain endothelium, the choroid plexus epithelium, and the arachnoid epithelium. Drug exposure to the CNS is partially dependent on the physical barrier presented by the blood-brain and blood-CSF barrier and the affinity of the substrate for specific transport systems located at both of these interfaces. The choroid plexus epithelium, together with the arachnoid epithelium and the circumventricular organs collectively constitute the blood-CSF barrier. The choroid plexus is involved in the production and secretion of CSF. Our understanding of choroid plexus developmental biology is extremely limited. The proposed studies aim at exploring the molecular and cellular mechanisms underlying the formation of the choroid plexus. More specifically, using a combination of molecular, cellular and embryological approaches, morphogenesis and maturation of the choroid plexus and the mechanisms that guide its formation as well as the establishment of its barrier functions will be addressed in the context of the developing animal and in cell culture-based assays. Our general aim is to provide a comprehensive characterization of the choroid plexus, the central element of the blood-CSF barrier and an important, yet overlooked structure in the brain, 1 that may be potentially explored as a target for drug and gene delivery strategies for the treatment of neurological diseases.
描述(由申请人提供):血液组织屏障保护中枢神经系统,代表中枢神经系统和外周循环之间的主要界面。对屏障的破坏导致许多神经系统疾病发展中的长期神经毒性。在脑内皮、脉络丛上皮和蛛网膜上皮中发现屏障。药物暴露于CNS部分取决于血脑屏障和血CSF屏障的物理屏障以及底物对位于这两个界面的特定转运系统的亲和力。脉络丛上皮与蛛网膜上皮和室周器官共同构成血-CSF屏障。脉络丛参与CSF的产生和分泌。我们对脉络丛发育生物学的理解是非常有限的。这些研究旨在探索脉络丛形成的分子和细胞机制。更具体地说,使用分子,细胞和胚胎学的方法,形态发生和脉络丛的成熟和机制,指导其形成以及建立其屏障功能的组合将在发展中的动物的背景下,并在细胞培养为基础的测定。我们的总体目标是提供脉络丛的全面表征,脉络丛是血液-CSF屏障的中心要素,也是大脑中一个重要但被忽视的结构,1它可能被探索为治疗神经系统疾病的药物和基因递送策略的靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Angeliki Louvi其他文献

Angeliki Louvi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Angeliki Louvi', 18)}}的其他基金

Brain Cholesterol Biosynthesis in Health and Neurological Disease
健康和神经系统疾病中的脑胆固醇生物合成
  • 批准号:
    10574830
  • 财政年份:
    2022
  • 资助金额:
    $ 18.46万
  • 项目类别:
Molecular Mechanisms of Primary Microcephaly
原发性小头畸形的分子机制
  • 批准号:
    8617855
  • 财政年份:
    2013
  • 资助金额:
    $ 18.46万
  • 项目类别:
Molecular Mechanisms of Primary Microcephaly
原发性小头畸形的分子机制
  • 批准号:
    8482402
  • 财政年份:
    2013
  • 资助金额:
    $ 18.46万
  • 项目类别:
Development of Choroid Plexus and the Blood-CSF Barrier
脉络丛和血脑脊液屏障的发育
  • 批准号:
    6959213
  • 财政年份:
    2005
  • 资助金额:
    $ 18.46万
  • 项目类别:

相似海外基金

ICF: Enhancing Blood-Brain Barrier Opening with Ultrasound and Microwaves for Targeted Drug Delivery
ICF:利用超声波和微波增强血脑屏障开放以实现靶向药物输送
  • 批准号:
    MR/Z503848/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Research Grant
Venom-derived blood-brain-barrier shuttles
毒液衍生的血脑屏障穿梭机
  • 批准号:
    DP230102707
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Discovery Projects
Development of blood-brain barrier-penetrating oligosaccharides
穿透血脑屏障寡糖的开发
  • 批准号:
    23K11852
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Defining mechanisms of blood-brain barrier dysfunction in cerebral small vessel disease using advanced 3D in vitro models.
使用先进的 3D 体外模型定义脑小血管疾病血脑屏障功能障碍的机制。
  • 批准号:
    MR/W027119/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Fellowship
Understanding suppression of transcytosis in formation of the blood-brain barrier (BBB) and how Calcrl/Ramp2 signalling limits BBB permeability
了解血脑屏障 (BBB) 形成过程中转胞吞作用的抑制以及 Calcrl/Ramp2 信号如何限制 BBB 通透性
  • 批准号:
    MR/X008215/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
    Research Grant
The blood-brain barrier and Alzheimer pathology
血脑屏障和阿尔茨海默病病理学
  • 批准号:
    10800246
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
Bisphenol-Induced Blood-Brain Barrier Dysfunction in Alzheimer’s Disease
双酚引起的阿尔茨海默氏病血脑屏障功能障碍
  • 批准号:
    10713025
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
  • 批准号:
    10663717
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers
血脑屏障完整性和免疫动态导致新冠长途运输者的神经精神后遗症
  • 批准号:
    10688300
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
MicroRNAs, Mitochondria and the Blood-Brain Barrier - Therapeutic Targets for Stroke
MicroRNA、线粒体和血脑屏障——中风的治疗靶点
  • 批准号:
    10587899
  • 财政年份:
    2023
  • 资助金额:
    $ 18.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了